First Light Asset Management, LLC Zymeworks Inc. Transaction History

First Light Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$26.5 - $38.23 $3.12 Million - $4.51 Million	-117,848 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $2.38 Million - $4.54 Million	-79,854 Reduced 40.39%	117,848 $3.72 Million
Q4 2020 Feb 16, 2021	BUY	$39.12 - $54.99 $106,993 - $150,397	2,735 Added 1.4%	197,702 $9.34 Million
Q3 2020 Nov 13, 2020	SELL	$29.21 - $46.58 $8.23 Million - $13.1 Million	-281,723 Reduced 59.1%	194,967 $9.08 Million
Q2 2020 Aug 14, 2020	BUY	$33.67 - $40.0 $11.2 Million - $13.3 Million	331,781 Added 228.96%	476,690 $17.2 Million
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $3.52 Million - $7.22 Million	144,909 New	144,909 $5.14 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.